BR0006634A - Extratos de matricária (tanacetum parthenium) contra distúrbios inflamatórios - Google Patents

Extratos de matricária (tanacetum parthenium) contra distúrbios inflamatórios

Info

Publication number
BR0006634A
BR0006634A BR0006634-6A BR0006634A BR0006634A BR 0006634 A BR0006634 A BR 0006634A BR 0006634 A BR0006634 A BR 0006634A BR 0006634 A BR0006634 A BR 0006634A
Authority
BR
Brazil
Prior art keywords
inflammatory disorders
feverfew
extract
treating
related conditions
Prior art date
Application number
BR0006634-6A
Other languages
English (en)
Other versions
BRPI0006634B1 (pt
BRPI0006634B8 (pt
Inventor
Theresa Callaghan
Thierry Oddos
Gerard J Gendimenico
Katharine Martin
Original Assignee
Johnson & Johnson Comsumer Fra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0006634(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson Comsumer Fra filed Critical Johnson & Johnson Comsumer Fra
Publication of BR0006634A publication Critical patent/BR0006634A/pt
Publication of BRPI0006634B1 publication Critical patent/BRPI0006634B1/pt
Publication of BRPI0006634B8 publication Critical patent/BRPI0006634B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Patente de Invenção: <B> "EXTRATOS DE MATRICáRIA (TANACETUM PARTHENIUM) CONTRA DISTúRBIOS INFLAMATóRIOS"<D>. Esta invenção refere-se a um processo de tratamento e de prevenção de distúrbios inflamatórios e condições relacionadas que usa um extrato de matricária. Particularmente, a invenção inclui um processo de tratamento e de prevenção de distúrbios inflamatórios e condições relacionadas que compreende a aplicação de uma composição tópica que compreende uma quantidade eficaz de um extrato de matricária a um paciente e um processo de tratamento e de prevenção de distúrbios inflamatórios e condições relacionadas da pele por aplicação de uma composição tópica que contém uma quantidade de eficaz de um extrato de matricária a um paciente. Além disso, a invenção inclui um processo de tratamento e de prevenção de distúrbios inflamatórios e condições relacionadas da pele por aplicação de uma composição tópica que contém uma quantidade de eficaz de um extrato de matricária a um paciente em que o dito extrato é substancialmente isento de gama-lactona alfa-insaturada.
BRPI0006634A 1999-06-03 2000-06-02 composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios BRPI0006634B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13733299P 1999-06-03 1999-06-03
PCT/US2000/015125 WO2000074699A1 (en) 1999-06-03 2000-06-02 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
US09/586,587 US6410062B1 (en) 1999-06-03 2000-06-02 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)

Publications (3)

Publication Number Publication Date
BR0006634A true BR0006634A (pt) 2001-05-02
BRPI0006634B1 BRPI0006634B1 (pt) 2015-06-02
BRPI0006634B8 BRPI0006634B8 (pt) 2021-05-25

Family

ID=22476913

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0006634A BRPI0006634B8 (pt) 1999-06-03 2000-06-02 composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios

Country Status (14)

Country Link
US (1) US6410062B1 (pt)
EP (1) EP1100516B1 (pt)
JP (1) JP2004500329A (pt)
KR (1) KR100755798B1 (pt)
CN (1) CN1319020A (pt)
AT (1) ATE291433T1 (pt)
AU (1) AU778261B2 (pt)
BR (1) BRPI0006634B8 (pt)
CA (1) CA2339221C (pt)
DE (1) DE60018881T2 (pt)
ES (1) ES2239010T3 (pt)
MX (1) MXPA01001327A (pt)
PT (1) PT1100516E (pt)
WO (1) WO2000074699A1 (pt)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
JP2004524335A (ja) * 2001-03-16 2004-08-12 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド フィーバーフュー抽出物を含む組成物およびその使用方法
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20020185426A1 (en) * 2001-04-26 2002-12-12 Bealer Leroy J. Environmental flexible remediation system
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
MY139332A (en) * 2002-05-22 2009-09-30 Hovid Berhad Hair growth formulation
DE60318237T2 (de) 2002-10-24 2008-12-18 Immupharm A/S Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040161436A1 (en) * 2003-02-13 2004-08-19 Hull Barbara A. Skin treatment composition and method
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050003025A1 (en) * 2003-06-30 2005-01-06 Hargens Robert D. Method of mitigating the odor of valerian extracts
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
EP1543822A1 (en) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Soy containing formulations for the improvement of skin radiance
EP1543823A1 (en) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingko containing formulations for the improvement of skin radiance
US20050244480A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Pre-wipes for improving anal cleansing
US20060003654A1 (en) * 2004-06-30 2006-01-05 Lostocco Michael R Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers
US20060147484A1 (en) * 2005-01-03 2006-07-06 Hestand Mark A Urushiol-induced contact dermatitis composition, method of use, and method of manufacture
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
WO2006128169A2 (en) * 2005-05-26 2006-11-30 The Ohio State University Research Foundation Inhibition of monocyte survival, differentiation, or proliferation
US20100227826A1 (en) * 2005-12-07 2010-09-09 Mercier Michel F Stable Flavonoid Solutions
CA2643255A1 (en) * 2006-02-21 2007-08-30 Integrated Botanical Technologies, Llc Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
CN101406514B (zh) * 2007-10-10 2011-03-23 徐柔云 一种治疗脚癣的外用药
JP2010013403A (ja) * 2008-07-04 2010-01-21 Kao Corp Ｎｆａｔシグナル阻害剤及びｎｆａｔシグナル阻害方法
FR2940127B1 (fr) * 2008-12-18 2013-07-12 Nolva Lab Compositions a usage cosmetique et dermatologique destinees a lutter contre le vieillissement de la peau et contenant un extrait titre de ginkgo biloba et un extrait purifie de lactoferrine
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
US8075931B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8075930B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
US8916209B2 (en) * 2009-10-02 2014-12-23 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
EP2542209A1 (en) 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
US20110262505A1 (en) * 2010-04-22 2011-10-27 Gina Athwal Seaweed-derived cosmetic compositions
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9173913B2 (en) * 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9724315B2 (en) * 2011-09-30 2017-08-08 Cmpd Licensing, Llc Compounded transdermal pain management
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
US9468599B2 (en) 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
FR3015299B1 (fr) * 2013-12-20 2017-10-06 Oreal Dispositif d'iontophorese a gestion independante de courant
US10352605B2 (en) * 2017-02-14 2019-07-16 Heatcraft Refrigerator Products, LLC Cooling system with intermediate heat exchange fluid loop
KR102157755B1 (ko) * 2018-12-28 2020-09-18 경희대학교 산학협력단 운카리나 스텔루리페라 추출물을 유효성분으로 포함하는 항염증 또는 항아토피 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
US6103218A (en) 1997-04-23 2000-08-15 Brucker; Donald Therapeutic nasal spray administered composition containing feverfew
DE69808790T3 (de) * 1997-09-12 2009-07-16 The Procter & Gamble Co., Cincinnati Hautreinigungs- und konditionierungsartikel für haut und haar

Also Published As

Publication number Publication date
CA2339221C (en) 2013-09-10
DE60018881T2 (de) 2006-02-16
EP1100516B1 (en) 2005-03-23
BRPI0006634B1 (pt) 2015-06-02
CN1319020A (zh) 2001-10-24
KR100755798B1 (ko) 2007-09-07
AU778261B2 (en) 2004-11-25
JP2004500329A (ja) 2004-01-08
PT1100516E (pt) 2005-07-29
ATE291433T1 (de) 2005-04-15
EP1100516A1 (en) 2001-05-23
US6410062B1 (en) 2002-06-25
WO2000074699A1 (en) 2000-12-14
DE60018881D1 (de) 2005-04-28
ES2239010T3 (es) 2005-09-16
KR20010072221A (ko) 2001-07-31
CA2339221A1 (en) 2000-12-14
AU5313000A (en) 2000-12-28
MXPA01001327A (es) 2002-11-29
BRPI0006634B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BR0006634A (pt) Extratos de matricária (tanacetum parthenium) contra distúrbios inflamatórios
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
DK1137409T3 (da) Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
DE60229971D1 (de) Zubereitungen zur reizhemmenden rosacea-behandlung
ATE501722T1 (de) Therapeutische behandlung androgenrezeptorbedingter leiden
DK0801554T3 (da) Formuleringer og fremgangsmåder til reduktion af hudirritation
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0507895A (pt) composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
WO2004093722A3 (en) Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
BR9903750B1 (pt) utilização não terapêutica de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele.
AR054435A1 (es) Agente para profilaxis o terapia contra la depresion o desorden de ansiedad
MXPA04001289A (es) Composicion cosmetica y metodo para tratar la piel.
ATE322314T1 (de) Kosmetische hautbehandlungsmethode
WO2003092645A3 (fr) Composition cosmetique comprenant des mono- ou poly-saccharides
ES2134301T3 (es) Composicion farmaceutica para la profilaxis y el tratamiento de la eyaculacion precoz.
BR0204618A (pt) Métodos para tratamento de linhas finas e/ou de rugas, e para melhora a aparência estética da pele ou dos lábios, e, composição tópica
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények
BR0104082A (pt) Processo de tratamento conveniente para a deformação e/ou conformação, e isto de modo permanente, dos materiais queratìnicos e, particulamente, dos cabelos, composição cosmética redutora, e kit para tratamento

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/06/2015, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/28 (2006.01)

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/06/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 02/06/2020